Journals / Türk Oftalmoloji Dergisi / 2007 / Cilt: 37 - Sayı: 3

Surgical approach for the orbital implant exposure

Orbita implantı açılımında cerrahi yaklaşım

Pages
228–233
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

During the follow- up of all cases, a new exposure were not observed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this paper, treatment modalities for cases presenting with orbital implant exposure and their results are presented.
📊
Key Findings & Data:The study included 5 patients that applied to our oculoplastic service with an orbital implant exposure between the date of 2003-2005.
💡
Conclusion & Impact:During the follow- up of all cases, a new exposure were not observed.
🔬Design:Research Article
📍Scope:2003-2005 Verileri
⚙️Variables:Domain Parameters

Abstract

In this paper, treatment modalities for cases presenting with orbital implant exposure and their results are presented. The study included 5 patients that applied to our oculoplastic service with an orbital implant exposure between the date of 2003-2005. Three cases had underwent evisceration surgery and 2 cases had underwent enucleation surgery. There were 4 males and 1 female and the mean age was 47 years (range, 28-71 years). In 4 cases there were porous implants, in 1 case there was an acrylic implant. In 3 of the cases 2 months after surgery, in 1 case 4 years after surgery, in 1 case 8 years after surgery an orbital implant exposure was detected. The mean interval between the exposure and the revision was 10 months (range, 1-24 months).In I case the implant was extracted and due to patient's will, without another implant insertion a revision by tenon capsule and conjunctiva was performed. la-case which an acrylic sphere exposure occurred, a barrier was made by suturing the scleral flebs in front of the implant. In one case which an enucleation and implantation of dexon covered alumina implant had been performed, the same implant was inserted backward as possible as and closed by tenon capsule and conjunctiva. In two cases which had underwent evisceration and a porous implant had been inserted were performed posterior sclerotomy and secondary orbital implantation. During the follow- up of all cases, a new exposure were not observed.

Özet

Bu çalışmanın amacı orbita implantı açılımı ile başvuran olgularda cerrahi yaklaşımlarımızı takdim etmek ve sonuçlarımızı tartışmaktır. 2003 -2005 yılları arasında implant açılımı ile oküloplasti polikliniğimize başvuran 5 hasta çalışma kapsamına alındı. Üç olgu eviserasyon, 2 olgu enükleasyon cerrahisi geçirmişti. Hastaların 4'ü erkek,l'i kadın olup yaş ortalamaları 47 (28 -71 yıl) idi. Dört olguda poröz, 1 olguda akrilik implant mevcuttu. Olgulardan üçünde ameliyat sonrası ilk 2 ayda, birinde 4., diğerinde ise 8. yılda açılım tesbit edilmişti. Açılma ve revizyon arasındaki süre ortalama 10 ay (1 -24 ay) idi. Bir olguda implant çıkarıldı ve hastanın isteği üzerine başka implant takılmadan tenon ve konjonktiva kapatıldı. Akrilik sfer açılması olan diğer bir olguda, hazırlanan sklera flepleri imp lant önünde sütüre edilerek bariyer oluşturuldu. Enükleasyon yapılmış ve dexon kaplı alumina implant yerleştirilmiş bir olguda ise aynı implant mümkün olduğunca geriye doğru yerleştirile rek tenon ve konjonktiva kapatıldı. Eviserasyon yapılıp, poröz implant yerleştirilmiş iki olguda ise posterior sklerotomi ve sekonder sfer implantasyönu yapıldı. Olguların tümünde izlemler boyunca yeniden açılma gözlenmedi.

🔖

Cite This Article

ÖNDER, F., ÖZAY, S., ERDEMİR, D. E. (2022). Surgical approach for the orbital implant exposure. Türk Oftalmoloji Dergisi, Cilt: 37 - Sayı: 3, 228–233. https://ajindex.com/articles/638656

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Inkster CF, Stephen GJ, Leatherbarrow B: Primary ban ked scleral patch graft in the prevention of exposure of hydroxyapatite orbital implants. Ophthalmology 2002; 109: 389-92
  2. Naugle TC, Lee AM, Haik BG, Callahan MA: Wrapping hydroxyapatite orbital implants with posterior auricular muscle complex grafts. Am J Ophthalmol 1999; 128:495-501
  3. Lee V, Sharpe IS, Hungerford JL, Davies NP, Logani S: Exposure of primary orbital implants in postenucleation retinoblastoma patients. Ophthalmology 2000; 107:940-6
  4. Nolan LM, O'Keefe M, Lanigan B: Hydroxyapatite orbi tal implant exposure in children. J AAPOS 2003;7:345-8
  5. Christmas NJ, Quill KV, Murray TG, Gordon CD, Garon zik S, Tse D, Johnson T, Schiffman J, O'Brien JM: Evalu ation of efficacy and complications. Arch Ophthalmol 2000; 118:503-6
  6. Liao SL, Kao SCS, Tseng JHS, Lin LL-K: Surgical cove rage of exposed hydroxyapatite implant with retroauricu lar myoperiosteal graft. Br J Ophthalmol 2005;89:92-5
  7. Sagoo MS, Olver JM: Autogenous temporalis fascia patch graft for porous polyethylene (Medpor) sphere orbi tal implant exposure. Br J Ophthalmol 2004;88:942-6
  8. Cheng MS, Liao SL, Lin LL-K: Late porous polyethylene implant exposure after motility coupling post placement. Am J Ophthalmol 2004;138:420-4
  9. Suter AJ, Molteno ACB, Bevin TH, Fulton JD, Herbison P: Long term follow up of bone derived hydroxyapatite orbital implants. Br J Ophthalmol 2002;86:1287-92
  10. Banaz A, Aydın O, Arslan MO: Anoftalmik orbital imp lant olarak poröz polietilen sonuçları. T Oft Gaz 2005; 35: 346-51
  11. Akarsu C, Ünal M, Toklu Y, Hasanreisoğlu B: Orbita implant atılımının cerrahi tedavisinde alternatif yaklaşım lar. T Klin Oftalmoloji Dergisi 2000; 9 (1): 17-23.